Päivi Leisti, Anna Pankakoski, Jari Jokelainen, Laura Huilaja, Jaana Panelius, Kaisa Tasanen, & Outi Varpuluoma. (2024). Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid. Medical Journals Sweden.
Chicago Style (17th ed.) CitationPäivi Leisti, Anna Pankakoski, Jari Jokelainen, Laura Huilaja, Jaana Panelius, Kaisa Tasanen, and Outi Varpuluoma. Type 2 Diabetes and Its Treatment with Linagliptin Are Both Associated with Elevated Mortality in Bullous Pemphigoid. Medical Journals Sweden, 2024.
MLA (9th ed.) CitationPäivi Leisti, et al. Type 2 Diabetes and Its Treatment with Linagliptin Are Both Associated with Elevated Mortality in Bullous Pemphigoid. Medical Journals Sweden, 2024.
Warning: These citations may not always be 100% accurate.